HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 43 filers reported holding HARPOON THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $205,046 | +26221.7% | 288,797 | -72.4% | 0.00% | – |
Q1 2023 | $779 | -13.2% | 1,046,523 | -15.3% | 0.00% | – |
Q4 2022 | $897 | -99.9% | 1,236,289 | +81.5% | 0.00% | – |
Q3 2022 | $661,000 | -40.3% | 681,172 | +17.5% | 0.00% | -100.0% |
Q2 2022 | $1,108,000 | +1144.9% | 579,919 | +3145.9% | 0.00% | – |
Q1 2022 | $89,000 | -88.4% | 17,866 | -82.4% | 0.00% | – |
Q4 2021 | $768,000 | -83.9% | 101,775 | -83.1% | 0.00% | -100.0% |
Q3 2021 | $4,762,000 | +261.0% | 602,752 | +534.1% | 0.00% | +200.0% |
Q2 2021 | $1,319,000 | -42.6% | 95,063 | -13.5% | 0.00% | 0.0% |
Q1 2021 | $2,299,000 | -23.6% | 109,917 | -39.3% | 0.00% | -50.0% |
Q4 2020 | $3,010,000 | -9.2% | 181,207 | -9.2% | 0.00% | -60.0% |
Q2 2020 | $3,315,000 | +249.3% | 199,673 | +143.7% | 0.01% | +150.0% |
Q1 2020 | $949,000 | -20.8% | 81,937 | +1.1% | 0.00% | +100.0% |
Q4 2019 | $1,198,000 | +478.7% | 81,020 | +408.7% | 0.00% | – |
Q2 2019 | $207,000 | -82.7% | 15,928 | -87.4% | 0.00% | -100.0% |
Q1 2019 | $1,199,000 | – | 126,656 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |